Semler Scientific (SMLR) Announces Additional Bitcoin Purchases
Get Alerts SMLR Hot Sheet
Join SI Premium – FREE
Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced that it has purchased an additional 83 bitcoins for
"We recently purchased additional bitcoins using primarily cash from operations as well as capital raised through our at-the-market equity program," said
About Semler Scientific, Inc.:
Semler Scientific, Inc. develops, manufactures and markets innovative products and services to combat chronic diseases. Its flagship product, QuantaFlo®, which is patented and cleared by the U.S. Food and Drug Administration (FDA), is a rapid point-of-care test that measures arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of cardiovascular diseases, such as peripheral arterial disease (PAD), and Semler Scientific is seeking a new 510(k) clearance for expanded-indications. QuantaFlo is used by healthcare providers to evaluate their patient's risk of mortality and major adverse cardiovascular events (MACE). Semler Scientific also invests in bitcoin and has adopted bitcoin as its primary treasury asset. Additional information about Semler Scientific can be found at www.semlerscientific.com.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abbott settles preterm formula NEC lawsuits for $670 million
- Blue Moon Metals cleared to build at Nevada tungsten project
- GitLab releases version 19.3 with AI gateway and secrets tools
Create E-mail Alert Related Categories
Corporate NewsRelated Entities
Bitcoin, Maynard Um, Mark Zuckerberg, FDA, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share